Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.33 |
| ▸ | RET | P07949 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30540754 | 0.85 | EGFR (0.37) | CYP4F2CYP4A11RET | |
| SCHEMBL30713609 | 0.85 | CYP4F2 (0.31) | CYP4F2CYP4A11RET | |
| SCHEMBL24606751 | 0.85 | ATR (0.30) | CYP4F2CYP4A11RET | |
| SCHEMBL31712815 | 0.85 | CYP4F2 (0.31) | CYP4F2CYP4A11RET | |
| SCHEMBL30540775 | 0.83 | RET (0.32) | CYP4F2CYP4A11RET | |
| SCHEMBL31361807 | 0.81 | ATR (0.36) | CYP4F2CYP4A11RET | |
| SCHEMBL31327357 | 0.78 | CYP4F2 (0.34) | CYP4F2CYP4A11RET | |
| SCHEMBL31190602 | 0.78 | CYP4F2 (0.44) | CYP4F2CYP4A11MEN1ALDH1A1KMT2A | |
| SCHEMBL24607090 | 0.78 | CYP4F2 (0.34) | CYP4F2CYP4A11RETMAPT | |
| SCHEMBL29712202 | 0.78 | CYP4F2 (0.34) | CYP4F2CYP4A11RETMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119183452-A | LRRK2 inhibitors | 布雷宁疗法公司 | 2024-12-24 | — | — | CN | disclosed |
| WO-2024220747-A2 | FLUORINATED CYCLIC DERIVATIVES OF SULFONAMIDES AND SULFONES, AND COMPOSITIONS AND METHODS THEREOF | Lysoway Therapeutics, Inc. (US) | 2024-10-24 | — | — | WO | disclosed |